Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura M Selfors

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Plos One|November 16, 2018
CRB3 and the FERM protein EPB41L4B regulate proliferation of mammary epithelial cells through the release of amphiregulinStephanie J Walker, Laura M Selfors, Ben L Margolis, et al.
Breast Cancer Research : BCR|August 17, 2013
Evidence for a multipotent mammary progenitor with pregnancy-specific activityAlice S Kaanta, Carl Virtanen, Laura M Selfors, et al.
NPJ Breast Cancer|June 27, 2017
Niche-localized tumor cells are protected from HER2-targeted therapy via upregulation of an anti-apoptotic program in vivoJason J Zoeller, Roderick T Bronson, Laura M Selfors, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 13, 2017
Identification of cancer genes that are independent of dominant proliferation and lineage programsLaura M Selfors, Daniel G Stover, Isaac S Harris, et al.
NPJ Breast Cancer|September 27, 2017
Erratum: Niche-localized tumor cells are protected from HER2-targeted therapy via upregulation of an anti-apoptotic program in vivoJason J Zoeller, Roderick T Bronson, Laura M Selfors, et al.
Nature Cell Biology|January 23, 2009
Identification of genes that regulate epithelial cell migration using an siRNA screening approachKaylene J Simpson, Laura M Selfors, James Bui, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2016
The Role of Proliferation in Determining Response to Neoadjuvant Chemotherapy in Breast Cancer: A Gene Expression-Based Meta-AnalysisDaniel G Stover, Jonathan L Coloff, William T Barry, et al.
Plos One|May 5, 2021
Clinical evaluation of BCL-2/XL levels pre- and post- HER2-targeted therapyJason J Zoeller, Michael F Press, Laura M Selfors, et al.
Science Signaling|March 3, 2016
Cytokinesis involves a nontranscriptional function of the Hippo pathway effector YAPDuyen Amy Bui, Wendy Lee, Anne E White, et al.
Cancer Cell|February 21, 2012
Inhibition of PI3K/mTOR leads to adaptive resistance in matrix-attached cancer cellsTaru Muranen, Laura M Selfors, Devin T Worster, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Plos One|November 16, 2018
CRB3 and the FERM protein EPB41L4B regulate proliferation of mammary epithelial cells through the release of amphiregulinStephanie J Walker, Laura M Selfors, Ben L Margolis, et al.
Breast Cancer Research : BCR|August 17, 2013
Evidence for a multipotent mammary progenitor with pregnancy-specific activityAlice S Kaanta, Carl Virtanen, Laura M Selfors, et al.
NPJ Breast Cancer|June 27, 2017
Niche-localized tumor cells are protected from HER2-targeted therapy via upregulation of an anti-apoptotic program in vivoJason J Zoeller, Roderick T Bronson, Laura M Selfors, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 13, 2017
Identification of cancer genes that are independent of dominant proliferation and lineage programsLaura M Selfors, Daniel G Stover, Isaac S Harris, et al.
NPJ Breast Cancer|September 27, 2017
Erratum: Niche-localized tumor cells are protected from HER2-targeted therapy via upregulation of an anti-apoptotic program in vivoJason J Zoeller, Roderick T Bronson, Laura M Selfors, et al.
Nature Cell Biology|January 23, 2009
Identification of genes that regulate epithelial cell migration using an siRNA screening approachKaylene J Simpson, Laura M Selfors, James Bui, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2016
The Role of Proliferation in Determining Response to Neoadjuvant Chemotherapy in Breast Cancer: A Gene Expression-Based Meta-AnalysisDaniel G Stover, Jonathan L Coloff, William T Barry, et al.
Plos One|May 5, 2021
Clinical evaluation of BCL-2/XL levels pre- and post- HER2-targeted therapyJason J Zoeller, Michael F Press, Laura M Selfors, et al.
Science Signaling|March 3, 2016
Cytokinesis involves a nontranscriptional function of the Hippo pathway effector YAPDuyen Amy Bui, Wendy Lee, Anne E White, et al.
Cancer Cell|February 21, 2012
Inhibition of PI3K/mTOR leads to adaptive resistance in matrix-attached cancer cellsTaru Muranen, Laura M Selfors, Devin T Worster, et al.
Pageof 5